Luke Roush co-founded Sovereign’s Capital in 2012, and is a Managing Partner for the firm. While living in Kuala Lumpur and Jakarta from 2013-2016, he opened the firm's operations in Asia. Luke is primarily focused on the firm's healthcare and consumer product investments. Prior to Sovereign’s Capital, Luke had twelve years of experience in global commercialization and business development at venture-backed and Fortune 500 companies. He was Vice President for Sales, Marketing, and Business Development at TransEnterix (NYSE:TRXC), a medical device company that developed and commercialized a minimally invasive surgical system in the US, Europe, and Asia. Prior to TransEnterix, he served as Chief Operating Officer at Liquidia Technologies (NASDAQ:LQDA), a nanotechnology company focused on biopharmaceutical applications. Luke previously served as global marketing manager for the neurovascular stroke business at Boston Scientific (NYSE:BSX). He also co-founded 410 Medical, a device company focused on fluid infusion in pediatric and adult emergency care. Luke graduated summa cum laude from Duke University, and later earned his MBA from The Fuqua School of Business. Luke resides in San Jose, California with his wife, Brooke, and their three children.